Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(2)

Detailed Status

Completed2

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed250%

unknown250%

Recent Activity

0 active trials

Showing 4 of 4

completednot_applicable

Impact of Schemas, Cognitive Emotion Regulation on Quality of Life of HIV Patients: Assessing Outcomes of CBT

NCT06123078

unknownnot_applicable

Online LTP+CaCBT for Treating Depression in British Mothers of African/Caribbean Heritage

NCT04820920

unknownnot_applicable

LTP+CaCBT for Treating Postnatal Depression and Improving Child Wellbeing in Jos Nigeria

NCT04644081

completednot_applicable

Developing and Testing of Culturally Adapted Cognitive Behavior Therapy (CaCBT) for Pashto Speaking Pakistanis and Afghans

NCT02797691

Clinical Trials (4)

Showing 4 of 4 trials

NCT06123078Not Applicable

Impact of Schemas, Cognitive Emotion Regulation on Quality of Life of HIV Patients: Assessing Outcomes of CBT

Completed

NCT04820920Not Applicable

Online LTP+CaCBT for Treating Depression in British Mothers of African/Caribbean Heritage

Unknown

NCT04644081Not Applicable

LTP+CaCBT for Treating Postnatal Depression and Improving Child Wellbeing in Jos Nigeria

Unknown

NCT02797691Not Applicable

Developing and Testing of Culturally Adapted Cognitive Behavior Therapy (CaCBT) for Pashto Speaking Pakistanis and Afghans

Completed

All 4 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 4